Table 1 |
|||
|
Animal models of proteinuria |
|||
|
Models |
Proteinuria |
Na handling |
Ref |
|
|
|||
|
Injection of PAN |
|||
|
Sprague Dawley rat |
10 g/mmol creat |
Ascites, edema |
[9] |
|
90 mg/mg creat |
Ascites, edema |
[9] |
|
|
3 g/24 h/kg body wt |
Ascites, edema |
[9] |
|
|
30 mg/ml |
Ascites, edema |
[9] |
|
|
Wild type B6/D2 mouse |
0.03 mg/mg creat |
[29] |
|
|
ApoE-/- mouse |
0.2 mg/ml |
[30] |
|
|
Cox2 tg mouse |
0.07 mg/mg creat |
[29] |
|
|
PRO/Re mouse |
0.7 g/24 h/kg body wt |
[31] |
|
|
|
|||
|
Injection of adriamycin |
|||
|
Sprague Dawley rat |
25 mg/mg creat |
Na retention |
[9] |
|
B6/D2 mouse |
0.04 mg/mg creat |
[41] |
|
|
Balb/c mouse |
23 mg/mg creat |
[42] |
|
|
Balb/c mouse |
226 mg/mg creat |
[43] |
|
|
129 mouse |
120 mg/mg creat |
Ascites |
[44] |
|
|
|||
|
Genetically modified mice |
|||
|
Laminin α5-/- |
200 mg/mg creat |
[32] |
|
|
Laminin β2-/- |
12 mg/ml |
[33] |
|
|
α-actinin-4-/- |
+ + |
[34] |
|
|
Nphs2-/- |
+ + + |
HTA |
[36] |
|
CD2-AP-/- |
+ + + |
[35] |
|
|
CD151-/- |
+ + + |
Edema |
[27] |
|
|
|||
|
Human CD34+ engraftment |
|||
|
NOD/SCID mouse |
0.04 mg/mg creat |
[37] |
|
|
|
|||
|
Proteinuria in PAN nephrotic rats is given as a function of the different units found in the literature. + + and + + + refers to increases in proteinuria as determined by western blotting. When available, functional data related to renal sodium handling are provided; HTA, hypertension. |
|||
|
Brideau and Doucet BMC Nephrology 2010 11:15 doi:10.1186/1471-2369-11-15 |
|||